To this regard, an in vitro and in vivo study reported that FGF21 attenuated the negative effects of amyloid β-peptide 25–35 on neuronal apoptosis, tau hyperphosphorylation, and oxidative stress in AD-like pathologies [73]. The gene discussed is MAPT; the disease is Alzheimer disease.